These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 34644706)

  • 1. The Predialysis Serum Sodium Level Modifies the Effect of Hemodialysis Frequency on Left-Ventricular Mass: The Frequent Hemodialysis Network Trials.
    Raimann JG; Chan CT; Daugirdas JT; Depner T; Greene T; Kaysen GA; Kliger AS; Kotanko P; Larive B; Beck G; Lindsay RM; Rocco MV; Chertow GM; Levin NW;
    Kidney Blood Press Res; 2021; 46(6):768-776. PubMed ID: 34644706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determinants of left ventricular mass in patients on hemodialysis: Frequent Hemodialysis Network (FHN) Trials.
    Chan CT; Greene T; Chertow GM; Kliger AS; Stokes JB; Beck GJ; Daugirdas JT; Kotanko P; Larive B; Levin NW; Mehta RL; Rocco M; Sanz J; Schiller BM; Yang PC; Rajagopalan S;
    Circ Cardiovasc Imaging; 2012 Mar; 5(2):251-61. PubMed ID: 22360996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effect of Increased Frequency of Hemodialysis on Volume-Related Outcomes: A Secondary Analysis of the Frequent Hemodialysis Network Trials.
    Raimann JG; Chan CT; Daugirdas JT; Depner T; Gotch FA; Greene T; Kaysen GA; Kliger AS; Kotanko P; Larive B; Lindsay R; Rocco MV; Chertow GM; Levin NW;
    Blood Purif; 2016; 41(4):277-86. PubMed ID: 26795100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of frequent hemodialysis on matrix metalloproteinases, their tissue inhibitors, and FGF23: Implications for blood pressure and left ventricular mass modification in the Frequent Hemodialysis Network trials.
    Chan CT; Kaysen GA; Beck GJ; Li M; Lo JC; Rocco MV; Kliger AS;
    Hemodial Int; 2020 Apr; 24(2):162-174. PubMed ID: 31826326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between hypervolemia, left ventricular hypertrophy and fibroblast growth factor 23 in hemodialysis patients.
    Unver S; Kavlak E; Gümüsel HK; Celikbilek F; Esertas K; Muftuoglu T; Kirilmaz A
    Ren Fail; 2015 Jul; 37(6):951-6. PubMed ID: 26030798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of increased frequency of hemodialysis on vitamin C concentrations: an ancillary study of the randomized Frequent Hemodialysis Network (FHN) daily trial.
    Raimann JG; Abbas SR; Liu L; Larive B; Beck G; Kotanko P; Levin NW; Handelman G;
    BMC Nephrol; 2019 May; 20(1):179. PubMed ID: 31101018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of increased frequency of hemodialysis on serum cystatin C and β2-microglobulin concentrations: A secondary analysis of the frequent hemodialysis network (FHN) trial.
    Huang SS; Kaysen GA; Levin NW; Kliger AS; Beck GJ; Rocco MV; Filler G; Lindsay RM;
    Hemodial Int; 2019 Jul; 23(3):297-305. PubMed ID: 30861262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of frequent hemodialysis on ventricular volumes and left ventricular remodeling.
    Chan CT; Greene T; Chertow GM; Kliger AS; Stokes JB; Beck GJ; Daugirdas JT; Kotanko P; Larive B; Levin NW; Mehta RL; Rocco M; Sanz J; Yang PC; Rajagopalan S;
    Clin J Am Soc Nephrol; 2013 Dec; 8(12):2106-16. PubMed ID: 23970131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of short daily hemodialysis and extended standard hemodialysis on blood pressure and cardiac hypertrophy: a comparative study.
    Fagugli RM; Pasini P; Pasticci F; Ciao G; Cicconi B; Buoncristiani U
    J Nephrol; 2006; 19(1):77-83. PubMed ID: 16523430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of dialysate to serum sodium (Na
    Raimann JG; Ficociello LH; Usvyat LA; Zhang H; Pacelli L; Moore S; Sheppard P; Xiao Q; Wang Y; Mullon C; Balter P; Sullivan T; Kotanko P
    BMC Nephrol; 2018 Apr; 19(1):75. PubMed ID: 29609536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in Biomarker Profile and Left Ventricular Hypertrophy Regression: Results from the Frequent Hemodialysis Network Trials.
    Chan CT; Kaysen GA; Beck GJ; Li M; Lo J; Rocco MV; Kliger AS;
    Am J Nephrol; 2018; 47(3):208-217. PubMed ID: 29621747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of left ventricular mass and hypertrophy in hemodialysis patients assessed by cardiac magnetic resonance imaging.
    Patel RK; Oliver S; Mark PB; Powell JR; McQuarrie EP; Traynor JP; Dargie HJ; Jardine AG
    Clin J Am Soc Nephrol; 2009 Sep; 4(9):1477-1483. PubMed ID: 19713289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of daily hemodialysis on heart rate variability: results from the Frequent Hemodialysis Network (FHN) Daily Trial.
    Chan CT; Chertow GM; Daugirdas JT; Greene TH; Kotanko P; Larive B; Pierratos A; Stokes JB;
    Nephrol Dial Transplant; 2014 Jan; 29(1):168-78. PubMed ID: 24078335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intensive Hemodialysis, Left Ventricular Hypertrophy, and Cardiovascular Disease.
    McCullough PA; Chan CT; Weinhandl ED; Burkart JM; Bakris GL
    Am J Kidney Dis; 2016 Nov; 68(5S1):S5-S14. PubMed ID: 27772643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of frequent hemodialysis on blood pressure: Results from the randomized frequent hemodialysis network trials.
    Kotanko P; Garg AX; Depner T; Pierratos A; Chan CT; Levin NW; Greene T; Larive B; Beck GJ; Gassman J; Kliger AS; Stokes JB;
    Hemodial Int; 2015 Jul; 19(3):386-401. PubMed ID: 25560227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Low-Sodium versus Conventional Sodium Dialysate on Left Ventricular Mass in Home and Self-Care Satellite Facility Hemodialysis Patients: A Randomized Clinical Trial.
    Marshall MR; Vandal AC; de Zoysa JR; Gabriel RS; Haloob IA; Hood CJ; Irvine JH; Matheson PJ; McGregor DOR; Rabindranath KS; Schollum JBW; Semple DJ; Xie Z; Ma TM; Sisk R; Dunlop JL
    J Am Soc Nephrol; 2020 May; 31(5):1078-1091. PubMed ID: 32188697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Left ventricular mass relates to average systolic blood pressure, but not loss of circadian blood pressure in stable hemodialysis patients: an ambulatory 48-hour blood pressure study.
    Nishikimi T; Minami J; Tamano K; Takahashi M; Numabe A; Futoo Y; Honda T; Kobayashi T; Uetake S; Mori Y; Saito T; Matsuoka H
    Hypertens Res; 2001 Sep; 24(5):507-14. PubMed ID: 11675944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodialysis-associated hypertension: pathophysiology and therapy.
    Hörl MP; Hörl WH
    Am J Kidney Dis; 2002 Feb; 39(2):227-44. PubMed ID: 11840363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Baseline characteristics of participants in the Frequent Hemodialysis Network (FHN) daily and nocturnal trials.
    Rocco MV; Larive B; Eggers PW; Beck GJ; Chertow GM; Levin NW; Kliger AS;
    Am J Kidney Dis; 2011 Jan; 57(1):90-100. PubMed ID: 21122961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nocturnal hemodialysis: analysis following the Frequent Hemodialysis Network trial.
    Stokes JB
    Semin Dial; 2011; 24(6):614-20. PubMed ID: 22122449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.